These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8895155)

  • 21. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury.
    Lohmander LS; Hoerrner LA; Dahlberg L; Roos H; Björnsson S; Lark MW
    J Rheumatol; 1993 Aug; 20(8):1362-8. PubMed ID: 8230020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lubricating ability of aspirated synovial fluid from emergency department patients with knee joint synovitis.
    Jay GD; Elsaid KA; Zack J; Robinson K; Trespalacios F; Cha CJ; Chichester CO
    J Rheumatol; 2004 Mar; 31(3):557-64. PubMed ID: 14994405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Degeneration of normal articular cartilage induced by late phase osteoarthritic synovial fluid in beagle dogs.
    Xu QR; Dong YH; Chen SL; Bao CD; Du H
    Tissue Cell; 2009 Feb; 41(1):13-22. PubMed ID: 18692211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type II collagen synthesis in the articular cartilage of a rabbit model of osteoarthritis: expression of type II collagen C-propeptide and mRNA especially during early-stage osteoarthritis.
    Hotta H; Yamada H; Takaishi H; Abe T; Morioka H; Kikuchi T; Fujikawa K; Toyama Y
    J Orthop Sci; 2005 Nov; 10(6):595-607. PubMed ID: 16307185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
    Myers SL; Brandt KD; Burr DB; O'Connor BL; Albrecht M
    J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis.
    Shinmei M; Ito K; Matsuyama S; Yoshihara Y; Matsuzawa K
    Osteoarthritis Cartilage; 1993 Apr; 1(2):121-8. PubMed ID: 8886088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cruciate ligament laxity and femoral intercondylar notch narrowing in early-stage knee osteoarthritis.
    Quasnichka HL; Anderson-MacKenzie JM; Tarlton JF; Sims TJ; Billingham ME; Bailey AJ
    Arthritis Rheum; 2005 Oct; 52(10):3100-9. PubMed ID: 16200589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
    Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
    Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals.
    Matyas JR; Ehlers PF; Huang D; Adams ME
    Arthritis Rheum; 1999 May; 42(5):993-1002. PubMed ID: 10323456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
    Aurich M; Squires GR; Reiner A; Mollenhauer JA; Kuettner KE; Poole AR; Cole AA
    Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY; Stabler TV; Criscione LG; Elliott AL; Jordan JM; Kraus VB
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
    Struglics A; Lohmander LS; Last K; Akikusa J; Allen R; Fosang AJ
    Arthritis Rheum; 2012 Dec; 64(12):4151-61; author reply 4162-3. PubMed ID: 22886575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy.
    Englund M; Lohmander LS
    Arthritis Rheum; 2004 Sep; 50(9):2811-9. PubMed ID: 15457449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide.
    Rousseau JC; Sandell LJ; Delmas PD; Garnero P
    Methods Mol Med; 2004; 101():25-37. PubMed ID: 15299208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis.
    Jung M; Christgau S; Lukoschek M; Henriksen D; Richter W
    Pathobiology; 2004; 71(2):70-6. PubMed ID: 14707441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of intermittent fluid pressure of low physiological magnitude on cartilage and inflammation in osteoarthritis. An in vitro study.
    van Valburg AA; van Roy HL; Lafeber FP; Bijlsma JW
    J Rheumatol; 1998 Mar; 25(3):515-20. PubMed ID: 9517773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis.
    Honsawek S; Tanavalee A; Sakdinakiattikoon M; Chayanupatkul M; Yuktanandana P
    Clin Biochem; 2009 Jun; 42(9):808-12. PubMed ID: 19217889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.